Regulatory Reforms-Future of Plasma Protein Therapy in India

Similar documents
NHPP9: National Programme for Blood Safety Quadrant I Personal details:

Essential Medicines. WHO

Asia s Diabetes Challenge

New Zealand Government Oversight of Halal Certification of Animal Products Exported from New Zealand Auckland University Asia Dialogue July 2012

Amul The innovative social enterprise

Strengthening Health Systems and Blood Services

MEETING OF DRUGS TECHNICAL ADVISORY BOARD HELD ON 1 ST APRIL, 2014 IN THE CHAMBER OF DGHS, NIRMAN BHAWAN, NEW DELHI

Plasma Fractionation Issues for Developing Countries DR YASMIN AYOB

Blood Banking in India: Ten Years Later

Blood Banking in India: Ten Years Later. Sue Johnson, MSTM, MT(ASCP)SBB Director, Clinical Education BloodCenter of Wisconsin Milwaukee, WI

New Drugs Division. Frequently Asked Questions (FAQs) on Approval of new Phytopharmaceutical Drugs

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Indian Pharmacopoeia Commission

Singapore s Progress on GLP and MAD

Managing cost considerations and access to technology for cost effective vaccine manufacture in developing countries.

Complementary and Alternative Medicine (CAM) Regulation and Education for Health Care Professionals: A Comparison between the UK and Hong Kong

Management of Blood Transfusion Services in India: An Illustrative Study of Maharashtra and Gujarat States

Botswana Private Sector Health Assessment Scope of Work

QSEAL Recovered Plasma Specification

NATIONAL HEALTH MISSION OF INDIA. Dr. Rajesh Kumar, MD PGIMER School of Public Health Chandigarh (India)

Overview of Blood Transfusion System of Iran:

2014/LSIF/PD/008 Building Blocks and Challenges to Implementing a National Blood Program in Malaysia

FROST & SULLIVAN. Publications Division - Terms and Conditions of Business

Technical matters: Traditional medicine: Delhi Declaration

WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES

Seeking Opportunities from Complex Regulatory Challenges for Halal Cosmetic Products in ASEAN Market

Cote d Ivoire: Family Planning and HIV Prevention

Call to Action. Global and Regional Hepatitis Action Plans: Opportunities and considerations for China

UN Panel Discussion Millennium Development Goals. Ajay Singh Senior Director Dr Reddy s Laboratories 07 July 2010

Harnessing the Cooperative Advantage to Build a Better World, Global Forum on Cooperatives, UNDESA, Addis Ababa, 4 6 September 2012,

Ministerial Round Table: Accelerating implementation of WHO FCTC in SEAR

14 th International Conference of Drug Regulatory Authorities : Progress report from the Western Pacific Region

Introduction to PAHWP-EAC-LSHTM Workshop on Assessment of Clinical Performance of in-vitro Diagnostics

AUCKLAND REGIONAL ALCOHOL FORUM. 2 June 2011

ASEAN Activities on Increasing Access to ARV and HIV Related Supplies

Summary results matrix: Government of Sri Lanka-UNICEF country programme,

CURRICULUM VITAE. Present Address : B-3, 13, Eskaton Garden Dhaka, Bangladesh.

HEPATITIS ELIMINATION IN SUB-SAHARAN AFRICA: WHAT WILL IT TAKE?

TGA regulation of local manufacturers of plasma derivatives CSL Behring Australia s overview

HARM REDUCTION IN ASIA. Adeeba Kamarulzaman University of Malaya, Kuala Lumpur

Prohibition of importation, manufacturing and sale of Smokeless Tobacco products.

World Heart Federation Roadmap on Tobacco Control: A situation analysis in India

Executive Board of the United Nations Development Programme and of the United Nations Population Fund

Help Thalassemia Child get Blood - Their Lifeline

GLP in the European Union Ecolabel detergents, GLP and accreditation

DONOR RECRUITMENT AND PLASMA COLLECTION IN INDONESIA. Yuyun SM Soedarmono Blood Services Committee Ministry of Health of Indonesia 1

HEALTH SYSTEM STRENGTHENING UNDER THE NATIONAL RURAL HEALTH MISSION (NRHM) IN INDIA

Where are we with the NCD Movement?

The European Neighbourhood Policy (ENP) ENP Coordination External Relations Directorate General European Commission

Innovation, Access and Use Department of Essential Medicines and Health Products WHO

Transfusion Medicine in Saudi Arabia

Indonesia-Intensified Iodine Deficiency Control Project. Ministry of Health (MOH)/Ministry of Industry (MOI)

9 th RSC Meeting of GF TADs for Asia and the Pacific

Por Ir National Institute of Public Health

The new WHO global injection safety policy and campaign

A REPORT ON INDUSTRIAL VISIT AT AMUL

39th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland. 6-8 December 2016

Pocket Guide to South Africa 2016/17. Pocket Guide to South Africa 2016/17

ENVIROMENTAL AND SOCIAL HEALTH DETERMINANTS IN ZANZIBAR

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Exporting Heart Disease to Developing Countries: India. Zeeshan Ali, Ph.D.

National Food Fortification Alliance (NFA)

GMP IN BLOOD ESTABLISHMENTS: A BASIC ELEMENT FOR PLASMA QUALITY

Traditional Medicine: Overview on national policies and regulations of traditional medicine

Pharmaceutical Biotechnology The Needs and Challenges of Innovation. Dr. Thomas Schreitmueller, Regulatory Policy, Biologics

Bangladesh. CARE-GSK Community Health Worker Initiative An innovative public private partnership

Myanmar and Birth Spacing: An overview

Vaccine Development in the Developing World; past, present and future: SEAR Perspective

Sl No. Subject Page. 1. Introduction 3 2. Detailed Reports 3. (1/1)Ladies Prompt-Country Fast 4 Purpose Of Camp 5 Research Plan 5

Meeting the MDGs in South East Asia: Lessons. Framework

Global Fund Approach to Health System Strengthening

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS

Breast Cancer in the Eastern Mediterranean Region A Burden with Potential. King Hussein Cancer Center

SECTOR ASSESMENT (SUMMARY): HEALTH

WHAT IS STAR? MALAWI ZAMBIA ZIMBABWE SOUTH AFRICA

Viral Hepatitis Prevention Board CREATIVE FINANCING SOLUTIONS TO SCALE UP PREVENTION & TREATMENT OF HBV/HCV

Tuberculosis. Ruth McNerney

2015/LSIF/FOR/009 Securing Political and Financial Support for Blood Safety - Philippine Experience

BULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January 2006 ISSN

Access to Healthcare for Women and Children. A Philips CSR Initiative. Sumathi/ Anoop 8/31/17 An overview

PROJECT ŚVETANA (Dawn) Elimination of new HIV infections among children by Scaling up PPTCT services in private health sector

Global In-Vitro-Fertilization Market: Trends and Opportunities ( )

The Millennium Development Goals and Sri Lanka

LIST OF ACRONYMS. Acquired Immune Deficiency Syndrome Community-Based Organisations Centre for the Development of People

EDINBURGH HEALTHCARE NHS TRUST. 4 Edinburgh Healthcare NHS Trust Printed Material,

Implementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB. Global Consultation

Government Agency Perspective on Future Access

Version for the Silent Procedure 29 April Agenda item January Hepatitis

Resolutions of the 50 th East, Central and Southern African Health Ministers Conference

OIE/FAO Global Conference on foot and mouth disease. The way towards global control. Paraguay: 24 to 26 June Draft Resolution version 8

OPERATIONAL FRAMEWORK. for the Global Strategy for Women s, Children s and Adolescents Health

Executive Board of the United Nations Development Programme and of the United Nations Population Fund

Tobacco & Poverty. Tobacco Use Makes the Poor Poorer; Tobacco Tax Increases Can Change That. Introduction. Impacts of Tobacco Use on the Poor

Gender Matters in GIZ

Plasma for fractionation: South African Plasma Requirements

An exploratory note on the differences in health in the two Bengals

CAPACITY BUILDING TRAINING WORKSHOP ON VIRAL HEPATITIS FOR AFRICAN UNION MEMBER STATES. Cairo, Egypt

Doing Business in India; Nutritional ingredients supplier perspective. Jaime Piza DSM Nutritional Products November, 2012

Transcription:

Regulatory Reforms-Future of Plasma Protein Therapy in India Ranjeet S. Ajmani PlasmaGen BioSciences Pvt. Ltd. Bangalore, India PPB-2013

Price Tag of Contrast q Uniqueness q Co-existence : Rich & Poor q Many Socio-Political complexities q Opportunities Education and Healthcare System PPB-2013

Introduction ² Human blood Transfusion Medicine and its components are defined as a Drug and regulated under Drugs & Cosmetics Act 1945 ² Normally blood collection, testing, component preparation, and dispensing is responsibility of blood banks ² Blood/plasma (generally) cannot move from blood bank to other ² Transfusion Medicine and Plasma Fractionation are very closely related ² Progress of one is dependent on other

1945: First blood bank in Kolkata Milestones 1954: Voluntary blood donation enhanced: 1962/65/71 wars 1975 : Blood bank licensing started with HBV, Syphilis & Malaria test 1988 : Hemophilia tragedy / HIV testing made mandatory 1989 : National Plasma Fractionation Center(NPFC), Mumbai 1992: National AIDS Control Programme (NACO) started 1996 : Supreme court Judgment against public litigation 1. National/State Blood Transfusion Council(s) (NBTC/SBTCs (1996) 2. Mandatory blood bank licensing (1997) 3. Professional donor banned (1998) 4. National Blood Policy ( 2002) formulated 2001 : HCV testing made mandatory 2005 : Recovered plasma collection permission/nib 2005 : Contract Plasma Fractionation started 2008-13 : New initiatives : Metro-Blood banks/pfc/ NBTA/BT Act

Regulatory Agencies involved Central Drugs Standard Control Organization (CDSCO) - Import & Registration (Plasma Products) National Institute of Biologicals, India - Testing samples (Plasma Products) The Central Drugs Testing Laboratory (CDTL) is another national statutory laboratory of the Government of India, its functions include Testing of imported bulk drugs and formulations referred by ADCs Indian Pharmacopeia

National Blood Transfusion Network and Plasma Products: Regulatory & Operational Framework Ministry of Health and Family Welfare Directorate General of Health Services (DGHS) National AIDS Control Organization( NACO) National Blood Transfusion Council (NBTC) State Blood Transfusion Council(SBTC) State Aids Control Organizations (SACS) Drug Controller General of India [ DCG (I)] State Drug Authority 4 Zonal offices National Institute of Biologicals (NIB) State level Blood Banks District Blood Banks Blood Storage Units Collection, Testing Processing, Storage & Distribution Distribution State Health Dept Licensing and Approval Authority

Regulatory Challenges Multiple organizations Poor Coordination Less trained manpower Outdated system Governance deficit : Regulator and Industry Delays and non-compliance ; Major Road Block

Serious Public Health Issue ² Hospital told to pay 10L to HIV-infected boy - Times Of India ² HIV infected Blood Transfusion: Latest News - The Times of India ² Woman gets HIV from 'infected' blood - Times Of India ² Frequency of HIV type 2 infections among blood donor population ² Andhra blood bank gives teen mom HIV - India Today ² Woman given HIV-infected blood - India Today ² HIV-infected thalassemic kids: Gujarat HC orders CBI Procedures

Blood Collection: Demand and Supply Sector No. of Blood Banks Annual Blood units collection (in million) Public 940 4.37 Voluntary and Trust 376 1.32 Pvt Hospitals 753 1.72 Private Stand alone 540 0.6 Total 2609 8.01 8.01 Vs 11.70 Millions Units 3.69 Millions Units

Comparative Scene S. No Country Population status (rank) Blood Collected Plasma Processed Million lit No of plants 1 USA III Highest ~ 11 8 2 China I II Highest ~ 4.1 17 3 India II III Highest??? 1 Largely import dependent

Plasma Fractionation in India ü Availability of plasma ü Regulatory deficiencies ü Technology barrier ü Uncertainties ü Historical view ü Poor public awareness ü Affordability ü Insurance ü No support from state ü Diagnosis ü Sustainable model ü Political will

PM s Speech on Republic day(26 Jan, 2012) 12 th Plan 5 year plan will focus on Public Health Universal health coverage(uhc) Planning commission High level expert group(hleg) Oct 2010 Planning commission s steering committee HLEG submitted Nov 2011 Human Resource for Health (HRH) National Commission for Human Resource for Health(NCHRH) National Drug Regulatory and Development Authority

Priority Safe drinking water Immunization Maternal mortality rate(mmr) Infant mortality rate(imr) Malnutrition Rural health program Public Health

Blood Plasma Products : Public Healthcare Agenda Assurance to timely access of quality, safe, efficacious drugs at affordable price Safe supply of blood and plasma products is very important public health concern v v v v Hemophilia care MMR Thalassemia care TTI

History of Public Litigation Ø Professional donor : 1995 Ø Hemophilia care : 2004 Ø Testing of Blood 2011 Ø Thalassemia Care 2013 Ø Use of Plasma 2013

Government: Under Pressure Policy : Mandate Regulation Financial resources R & D Infrastructure Treatment Rehabilitation

2001-2005 -2013: Plasma/ Plasma Products 0/ 8000/ 2-300,000 liters/yr No blood component lab to 300 labs Products from Indian plasma for Indian patients PPB-2013

DCGI : Regulatory Reforms Change in Drug and Cosmetic Act (D&C Act) : Major Changes and final draft has been submitted to Ministry in Jan 2012. Streamlining the entire blood banking system for safe supply of blood component and generation of plasma for fractionation Process of Regulation: WHO audit June/July 2012 Human Resource Training Documentation Audit Role of NACO : Blood Safety???? Plasma Fractionation Movement of Plasma PPB-2013

NIB : Regulatory Reforms First meeting on March 24, 2012 : Regulators, industry, Clinicians, NGOs and experts Second meeting in Sept 2012 Recommendation submitted : Nov 2012 Product Testing Protocols Viral markers in final products Product Monographs Product testing Timelines/Vials Batch release Number of vials Documentation PPB-2013

Hemovigilance : Public Healthcare Agenda First meeting on Aug 10. 2012 Background document : Sept 2012 Implementation plan : Oct. 2012 Software development : Nov. 2012 First steering committee workshop : Nov 29, 2012 Program goes live : Dec 10, 2012 Hemo

Hemovigilance : Public Healthcare Agenda In Asia : 3 rd country Feb 2013 : 80 Govt. and Private Hospitals and Medical Colleges Each center will have id and password No punitive action March 2013 : Data from 2 Govt and 1 Private hospital June 2013 : First report Step towards Biovigilance

IP: Regulatory Reforms New Products Improvement in IP compliance Harmonization PPB-2013

National Aids Control Organization (NACO) Blood Safety Program Increase voluntary donor base Quality assurance system Metro Blood Banks Mumbai Chennai Delhi Kolkata Plasma Fractionation Centre, Chennai Plasma requirement, policy and pricing

End point To work towards capacity building and develop ecosystem for timely, safe supply of ; Blood and blood components Plasma generation and its utilization for plasma product development program

Client/Manufacturer Documents Agent Documents & Samples DCGI/CDSCO (Annexure I & II) NIB (Annexure III) Import & Registration Import (Test License) Documents Review Samples Testing Documents Review

Inspired by the freedom movement. Milk became a symbol of protest. Founded in 1946 to stop the exploitation by middlemen Started: 2 Villages and 247 liters of milk at Kaira District Cooperative Milk Producers Union Ltd. Now : 15 million milk producers, 1,44,246 dairy cooperative societies across the country Processed in 177 District Co-operative Unions Marketed by 22 State Marketing Federations 2012 : 14.5 million liters/day Target 2018 : 18 million liters/day Currently, per capita availability of milk in India is 280 ml/day higher than the WHO's minimum recommendation UAE / Bahrain / Kuwait/ Oman / Hong Kong / Shri Lanka / USA / Malaysia / Singapore / Qatar/ New Zealand Rs.11,668 crores (Rs.116.68 billion)

India : Next 10 years : Plasma Fractionation One of the fastest growing economies : unsual pattern Evolved into hub for Medical Tourism Silicon Valley of east (Bangalore) Hub for clinical trials (Factor VIII) US-FDA approved plants Regulatory reforms Nation of youth Trained manpower Cost of setting-up Plasma Fractionation Center and operations PPB-2013

India :Plasma Fractionation Technically robust & financially sustainable model of plasma fractionation for developing economies PPB-2013